Altria Group, Inc.
Shortcut
1.49Normalized diluted EPS
-1.4% vs Street
Street
1.51Normalized diluted EPS
October 25 consensus snapshot
Real
1.52Altria issuer adjusted diluted EPS
Model download
Explore the assumptions and calculations behind the forecast.
Shortcut’s reasoning.
Revenue = revenues net of excise (consensus basis, verified vs all consensus history rows). Smokeable: domestic units -4.9% (cigarettes -5.1% on a 3Q25 comp flattered by trade-inventory build) x price realization +4.7% plus import-duty refunds $77m (3Q25 $20m) -> $4,629m; oral $664m; total $5,296m vs $5,310m consensus.
Smokeable adj. OCI $3,008m (+1.8%): margin ex-refunds held at 2Q26 64.4%, refunds at ~100% drop-through; oral adj. OCI $438m (-4.7%) as on! PLUS 12mg national launch adds trial spend (2Q26 call).
ABI equity income steps up to ~$194m (8.1% of ABI 2Q26 underlying profit $2,390m, +22.6% Y/Y; one-quarter lag) vs $157m in 3Q25; interest $270m; adjusted tax 23.0% (FY26 guide 22.5-23.5%).
On the record.
- Reporting period
- Q3 2026 (FQ3 2026 - Sep 2026)
- Reporting basis
- Altria adjusted diluted EPS, two-class common-share method, USD per NYSE common share
- Consensus snapshot
- October 25, 2026
- Model / effort
- Opus 5.5 · High effort
- Workbook
- Reviewed workbook
Record history
- Forecast generated
- Oct 26, 2026 at 5:00 PM PDT
- Reviewed revision completed
- Oct 26, 2026 at 5:00 PM PDT
- First published
- Oct 26, 2026 at 5:22 PM PDT
Result basis
The issuer Q3 Schedule 7 reconciliation reports diluted GAAP EPS 1.51 and adjusted-for-special-items diluted EPS 1.52. This uses the accepted USD diluted common-share convention. The reported issuer EPS is used directly, with no local reconstruction of the common-available numerator or altered participating-security treatment. The issuer Q3 2025 adjusted comparative 1.45 matches the frozen normalized history for that quarter. This check does not claim exhaustive item-level vendor definition equivalence.